Liabilities, Current in USD of Verona Pharma plc from Q4 2019 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Verona Pharma plc quarterly Liabilities, Current history and change rate from Q4 2019 to Q2 2025.
Verona Pharma plc Liabilities, Current for the quarter ending 30 Jun 2025 was $51.2M, a 5.98% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Verona Pharma plc Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$51.2M	+$2.89M	+5.98%	30 Jun 2025	10-Q	06 Aug 2025
Q1 2025	$56.5M	+$41.8M	+283%	31 Mar 2025	10-Q	29 Apr 2025
Q4 2024	$42.7M	+$34M	+391%	31 Dec 2024	10-Q	06 Aug 2025
Q3 2024	$28M	+$18.9M	+210%	30 Sep 2024	10-Q	04 Nov 2024
Q2 2024	$48.3M	+$37.4M	+342%	30 Jun 2024	10-Q	08 Aug 2024
Q1 2024	$14.8M	-$11.7M	-44.3%	31 Mar 2024	10-Q	10 May 2024
Q4 2023	$8.69M	-$10.3M	-54.3%	31 Dec 2023	10-K	27 Feb 2025
Q3 2023	$9.01M	-$23.1M	-72%	30 Sep 2023	10-Q	02 Nov 2023
Q2 2023	$10.9M	-$27.9M	-71.8%	30 Jun 2023	10-Q	03 Aug 2023
Q1 2023	$26.5M	-$11.4M	-30%	31 Mar 2023	10-Q	09 May 2023
Q4 2022	$19M	-$14.4M	-43.1%	31 Dec 2022	10-K	29 Feb 2024
Q3 2022	$32.1M	+$4.39M	+15.8%	30 Sep 2022	10-Q	09 Nov 2022
Q2 2022	$38.9M	-$19.5M	-33.4%	30 Jun 2022	10-Q	09 Aug 2022
Q1 2022	$37.9M	+$25.2M	+198%	31 Mar 2022	10-Q	03 May 2022
Q4 2021	$33.4M	+$19.2M	+135%	31 Dec 2021	10-K	07 Mar 2023
Q3 2021	$27.7M			30 Sep 2021	10-Q	09 Nov 2021
Q2 2021	$58.4M			30 Jun 2021	10-Q	05 Aug 2021
Q1 2021	$12.7M			31 Mar 2021	10-Q	29 Apr 2021
Q4 2020	$14.2M	+$1.36M	+10.6%	31 Dec 2020	10-K	03 Mar 2022
Q4 2019	$12.8M			31 Dec 2019	10-K	25 Feb 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.